1. Bowman, C. M., Porter, T. H., Skelton, F. S. and Folkers, K., 5,8-Quinolinequinone analogs which inhibit mitochondrial succinoxidase. J. Med. Chem., 16, 206–209 (1973).
2. Georgopapadakou, N. H. and Walsh, J., Human mycoses: Drugs and targets for emerging pathogens.Science, 264, 371–373 (1994).
3. Hudson, A. T., Atovaquone-A novel agent for the treatment of malaria, PCP and toxoplasmosis. In Bentley, P. H. and Ponsford, R. (Eds.).Recent Advances in the Chemistry of Anti-infective Agents. Royal Society of Chemistry, Cambridge, pp. 322–335, 1992.
4. Jeschke, P., Linder, W., Mueller, N. and Dehne, H. W., Fungicides based on amino-substituted quinolinequinones.Ger. Offen., DE 4,208,874 (1993).
5. Mcginnis M. R. and Rindali, M. G., Antifungal drug. In Lorian, V. (Eds.),Antibiotics in Laboratory Medicine (4th ed.). Williams and Wilkins, Baltimore, pp. 176–211, 1996.